Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction

Summary

Increased red blood cell distribution width (RDW), which is a marker of anisocytosis, is associated with mortality and cardiovascular events in the general population and in patients with heart failure or coronary heart disease. We investigated whether RDW in acute cerebral infarction is predictive of functional outcome and mortality. A total of 847 consecutive patients with first-ever acute cerebral infarction who presented to the emergency department within seven days of symptom onset were enrolled in this study. We investigated the association of RDW with poor functional outcome (modified Rankin Scale >2) and all-cause mortality at three months, as well as survival time for one year after stroke onset. Multivariate logistic regression revealed that higher RDW was independently associated with poor functional outcome (adjusted odds ratio [OR], 1.222 per 1% increment in RDW, 95% confidence interval [CI] 1.059–1.409, p=0.006) and all-cause death (adjusted OR, 1.395 per 1% increment in RDW, 95% CI 1.168–1.665, p<0.001) at three months after stroke onset. RDW was an independent predictor of survival in multivariate Cox-proportional regression model (adjusted hazard ratio, 1.328 per 1% increment in RDW, 95%CI 1.178–1.498, p<0.001). The addition of RDW to a survival model significantly increased predictability for survival across the entire follow-up period (weighted average of the area-under the curves, 0.858 vs. 0.841, p<0.05). In conclusion, higher RDW measured in cases of acute stage cerebral infarction was associated with poor functional outcome and mortality. RDW may be used as a biomarker for the prediction of long-term outcomes in patients with acute cerebral infarction.

Keywords

Cerebrovascular disease - stroke - mortality - red blood cell distribution width (RDW)

• References

• 1 Perlstein TS, Weuve J, Pfeffer MA. et al. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169: 588-594.
• 2 Pascual-Figal DA, Bonaque JC, Redondo B. et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009; 11: 840-846.
• 3 Patel KV, Ferrucci L, Ershler WB. et al. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169: 515-523.
• 4 Al-Najjar Y, Goode KM, Zhang J. et al. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 2009; 11: 1155-1162.
• 5 Felker GM, Allen LA, Pocock SJ. et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-47.
• 6 Dabbah S, Hammerman H, Markiewicz W. et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010; 105: 312-317.
• 7 Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am J Cardiol 2011; 107: 1241-1245.
• 8 Tonelli M, Sacks F, Arnold M. et al. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 2008; 117: 163-168.
• 9 Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 2009; 277: 103-108.
• 10 Easton JD, Saver JL, Albers GW. et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276-2293.
• 11 McKee PA, Castelli WP, McNamara PM. et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-1446.
• 12 Adams Jr HP, Bendixen BH, Kappelle LJ. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
• 13 Lee KY, Kim DI, Kim SH. et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004; 25: 1470-1475.
• 14 Parzen M, Lipsitz SR. A global goodness-of-fit statistic for Cox regression models. Biometrics 1999; 55: 580-584.
• 15 Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005; 61: 92-105.
• 16 Chen PC, Sung FC, Chien KL. et al. Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. Am J Epidemiol 2010; 171: 214-220.
• 17 Patel KV, Semba RD, Ferrucci L. et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci 2010; 65: 258-265.
• 18 Horne BD, May HT, Kfoury AG. et al. The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity end-points. Eur J Heart Fail 2010; 12: 1203-1213.
• 19 Poludasu S, Marmur JD, Weedon J. et al. Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost 2009; 102: 581-587.
• 20 van Kimmenade RR, Mohammed AA, Uthamalingam S. et al. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010; 12: 129-136.
• 21 Braun E, Domany E, Kenig Y. et al. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care 2011; 15: R194.
• 22 Oh HJ, Park JT, Kim JK. et al. Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrol Dial Transplant 2012; 27: 589-594.
• 23 Emans ME, van der Put ten K, van Rooijen KL. et al. Determinants of Red Cell Distribution Width (RDW) in Cardiorenal Patients: RDW is Not Related to Erythropoietin Resistance. J Card Fail 2011; 17: 626-633.
• 24 Allen LA, Felker GM, Mehra MR. et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010; 16: 230-238.
• 25 Forhecz Z, Gombos T, Borgulya G. et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158: 659-666.
• 26 Semba RD, Patel KV, Ferrucci L. et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr 2010; 29: 600-604.
• 27 Tauler P, Aguilo A, Gimeno I. et al. Influence of vitamin C diet supplementation on endogenous antioxidant defences during exhaustive exercise. Pflugers Arch 2003; 446: 658-664.
• 28 Wang S, Dale GL, Song P. et al. AMPKalpha1 deletion shortens erythrocyte life span in mice: role of oxidative stress. J Biol Chem 2010; 285: 19976-19985.
• 29 Ullegaddi R, Powers HJ, Gariballa SE. Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial. JPEN J Parenter Enteral Nutr 2006; 30: 108-114.
• 30 Cherubini A, Polidori MC, Bregnocchi M. et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000; 31: 2295-2300.
• 31 Ullegaddi R, Powers HJ, Gariballa SE. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr 2005; 59: 1367-1373.
• 32 Kaul DK, Koshkaryev A, Artmann G. et al. Additive effect of red blood cell rigidity and adherence to endothelial cells in inducing vascular resistance. Am J Physiol Heart Circ Physiol 2008; 295: H1788-1793.
• 33 Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 06: 76-82.
• 34 Wohner N, Sotonyi P, Machovich R. et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31: 2306-2313.
• 35 Yedgar S, Koshkaryev A, Barshtein G. The red blood cell in vascular occlusion. Pathophysiol Haemost Thromb 2002; 32: 263-268.
• 36 Mannucci PM. Red cells playing as activated platelets in thalassemia intermedia. J Thromb Haemost 2010; 08: 2149-2151.
• 37 Tikhomirova IA, Oslyakova AO, Mikhailova SG. Microcirculation and blood rheology in patients with cerebrovascular disorders. Clin Hemorheol Microcirc 2011; 49: 295-305.
• 38 Cappellini MD, Robbiolo L, Bottasso BM. et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467-473.
• 39 Wautier MP, Heron E, Picot J. et al. Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion. J Thromb Haemost 2011; 09: 1049-1055.
• 40 Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17: 571-577.
• 41 Kozuma Y, Sawahata Y, Takei Y. et al. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Hae-matol 2011; 152: 631-639.
• 42 Baskurt OK, Meiselman HJ. RBC aggregation: more important than RBC adhesion to endothelial cells as a determinant of in vivo blood flow in health and disease. Microcirculation 2008; 15: 585-590.
• 43 Yedgar S, Kaul DK, Barshtein G. RBC adhesion to vascular endothelial cells: more potent than RBC aggregation in inducing circulatory disorders. Microcirculation 2008; 15: 581-583.
• 44 Wohner N. Role of cellular elements in thrombus formation and dissolution. Cardiovasc Hematol Agents Med Chem 2008; 06: 224-228.